IWIda Bagus Rangga Wibhuti

Ida Bagus Rangga Wibhuti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ida Bagus Rangga Wibhuti has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nilai peak left atrial longitudinal strain (PALS) echocardiography sebagai prediktor silent atrial fibrillation (SAF) pada pasien embolic stroke of undetermined source akut (ESUS)

    by I Dewa Gede Surya Mahardika Badung, I Made Putra Swi Antara, Ida Bagus Rangga Wibhuti, Bagus Ari Pradnyana Dwi Sutanegara, I Made Junior Rina Artha, I Wayan Gede Artawan Eka Putra

    Background: Echocardiographic examination of left heart size and function has long been associated with cardioembolic mechanisms in stroke development, however, the diagnostic performance and comparison of atrial function measurements in this context have not been well studied. This study aims to identify whether atrial strain can be used as an imaging biomarker to predict atrial fibrillation (AF). Methods: This study was a prospective observational cohort design for acute ESUS stroke patients who met the inclusion and exclusion criteria, then underwent conventional echocardiography and left atrial speckle tracking measurements. Furthermore, during hospitalization, patients were observed using a 24-hour Holter monitor and electrocardiogram examination every day until the patient was discharged from the hospital. Demographic data, clinical characteristics, comorbidities, laboratory and echocardiographic parameters were included and compared as baseline characteristics of the study. Receiver operating curve (ROC) analysis, calculation of accuracy, sensitivity, and specificity, Kaplan Meier survival, and relative risk calculation were used in this study. Results: A total of 66 samples were included until the end of the study. The best cut-off point for PALS value was 14.0% with an area under the curve (AUC) value of 0.887 (p<0.001), sensitivity of 71.4% and specificity of 94.2% with PALS accuracy in predicting AF reaching 75.8%, for the probability of no AF in subjects with PALS <14% was 92.5%. In comparison, the STAF score had an AUC of 0.641 (95%CI: 0.513–0.755), while the CHA2D2VASC score was only 0.532 (95%CI: 0.406–0.656). The difference in AUC between PALS and STAF scores was 0.247 (p=0.0009), while the difference in AUC between PALS and CHA2D2VASC scores was 0.355 (p<0.0001). In contrast, there was no significant difference between STAF scores and CHA2D2VASC scores (p=0.2930). Risk analysis using relative risk (RR) of PALS scores on the incidence of AF with the results in the population with PALS scores <14% had a risk of AF events 6.99 times higher than PALS ≥14. Conclusion: PALS scores are independent predictors of AF events with good accuracy and specificity values. Further studies should examine the implications of these findings for AF monitoring or empirical antiremodeling and anticoagulation therapy. Latar belakang: Pemeriksaan ekokardiografi terhadap ukuran dan fungsi jantung kiri telah lama dikaitkan dengan mekanisme kardioemboli pada perkembangan stroke, namun, performa diagnostik dan perbandingan pengukuran fungsi atrium dalam konteks ini belum dipelajari dengan baik. Penelitian ini bertujuan untuk mengidentifikasi apakah regangan atrium dapat digunakan sebagai biomarker pencitraan untuk memprediksi fibrilasi atrium (FA). Metode: Penelitian ini dengan rancangan kohort prospectif observasional terhadap Pasien stroke ESUS akut yang memenuhi kriteria inklusi dan eksklusi, kemudian dilakukan pemeriksaan ekokardiografi konvensional dan pengukuran left atrial speckle tracking. Selanjutnya selama perawatan di rumah sakit pasien diobservasi dengan menggunakan 24 jam holter monitor dan pemeriksaan elektrokardiogram setiap harinya sampai pasien keluar dari rumah sakit. Data demografis, karakteristik klinis, komorbiditas, laboratorium dan parameter ekokardiografi disertakan dan dibandingkan sebagai karakteristik dasar penelitian. Analisis reciever operating curve (ROC), perhitungan akurasi, sensitivitas, dan spesifisitas, kesintasan Kaplan Meier, dan perhitungan risiko relatif digunakan dalam penelitian ini. Hasil: Sebanyak 66 sampel dilibatkan hingga akhir penelitian, tanpa ada sampel yang drop-out. Didapatkan cut-off point terbaik nilai PALS 14,0% dengan nilai area under the curve (AUC) 0,887 (p<001), sensitivitas 71,4% dan spesifisitas 94,2% dengan akurasi PALS dalam memprediksi kejadian atrial fibrillation (AF) mencapai 75,8%, untuk probabilitas tidak adanya silent AF (SAF) pada subjek dengan hasil pemeriksaan PALS <14% adalah 92,5%. Sebagai perbandingan, skor STAF memiliki AUC sebesar 0,641 (95% CI: 0,513–0,755), sedangkan skor CHA2D2VASC hanya sebesar 0,532 (95% CI: 0,406–0,656). Selisih AUC antara PALS dan skor STAF adalah 0,247 (p=0,0009), sedangkan selisih AUC antara PALS dan skor CHA2D2VASC lebih besar, yaitu 0,355 (p<0,0001). Sebaliknya, tidak ada perbedaan signifikan antara STAF score dan CHA2D2VASC score (p=0,2930). Analisis risiko menggunakan RR nilai PALS terhadap kejadian SAF dengan hasil pada populasi dengan skor PALS <14% memiliki risiko terhadap kejadian SAF sebesar 6,99 kali lebih tinggi dibandingkan dengan PALS ≥ 14. Simpulan: Nilai PALS merupakan prediktor independent terhadap kejadian SAF dengan nilai akurasi dan spesifisitas yang baik. Penelitian lebih lanjut harus memeriksa implikasi dari temuan ini untuk pemantauan FA atau terapi antiremodeling dan antikoagulasi empiris.

  • Open Access

    The association of Hs-Troponin I with cardiac dysfunction and structural changes in chronic heart failure with reduced ejection fraction patients

    by Luh Oliva Saraswati Suastika, I Gde Raka Widiana, I Wayan Wita, Agung Pranoto, Ida Bagus Rangga Wibhuti, Ni Made Ayu Wulan Sari, Melissa Dharmawan, Rizky Darmawan, Bagus Made Indrata Saputra

    Introduction: Cardiomyocyte death is the key pathological feature of heart failure with reduced ejection fraction (HFrEF). One of the circulating markers which represent myocardial cell death is cardiac troponin. High sensitivity-troponin I (hs-TnI) has been validated as an acute coronary syndrome diagnostic criteria. But its value and role in chronic heart failure, specifically HFrEF, has been variable in different studies. The aim of this study was to determine whether hs-TnI, an indicator of cardiomyocyte injury, is associated with functional and structural changes in HFrEF patients. Methods: A hospital-based cross-sectional analytic study was conducted on 72 patients with stable chronic HFrEF between April and October 2022. All subjects underwent echocardiography (Philips EPIQ7 and Affinity 70) and hs-troponin I serum measurement (Abbott Architect assay). Spearman’s test was used to evaluate the correlation between hs-troponin I and left ventricular ejection fraction (LVEF), E/A ratio, left ventricular end-diastolic volume (LVEDV), tricuspid annular plane systolic excursion (TAPSE) and left atrial volume index (LAVI). Results: hs-TnI concentrations were quantifiable in all samples ranging from 10 to 280.9 pg/mL. hs-TnI was associated significantly with LVEF (r=-0.39; p<0.01), E/A ratio (r=0.328, p=0.01), and LVEDV (r=0.278, p=0.04). hs-TnI was not correlated with TAPSE and LAVI (r=0.241; p=0.07 and r=-0.13; p=0.429, respectively). The correlation between hs-troponin I with LVEF, E/A ratio and LVEDV proved that the degree of myocardial injury is directly associated with left ventricle (LV) systolic and diastolic dysfunction and also with LV dilatation. While it is not correlated with right ventricle (RV) systolic function. Hs-TnI may represent the injury in LV better than RV. Conclusion: These findings support the association of hs-TnI as a circulating marker of cardiomyocyte injury with LV dysfunction (systolic and diastolic) and dilatation in chronic HFrEF patients. This has expanded the role of hs-TnI in chronic heart disease.

  • Open Access

    33 HYPERTENSION AND PRE-EXISTING COMORBIDITIES ASSOCIATES WITH MAJOR ADVERSE CARDIAC EVENTS IN CORONARY ARTERY DISEASE PATIENTS ADMITTED TO INTENSIVE CARDIOVASCULAR CARE UNIT IN SANGLAH HOSPITAL: THE MANY FACES OF A SILENT KILLER

    by P.S. Upadhana, I.G.G. Sastrawan, A.T.D. Putri, N.L.S. Darmayanti, G.N.P. Jagannatha, A.K. Umam, I.W.A.S. Pradnyana, I.G.A.A.C Cahyarini, A.R. Wijaya, I.B.R. Wibhuti

    Background: Coronary artery disease (CAD) patients with a history of hypertension and underlying comorbidities are at high risk of developing major adverse cardiac events (MACE) and increase the mortality of the patients. Objective: This study aims to determine the association of hypertension and MACE in CAD patients admitted to ICCU. Method: This research is an analytic study with a cross-sectional approach. The data used is secondary data from the records of patients who were admitted to ICCU at Sanglah Hospital on 1 January 2021- 31 December 2021 with total sampling technique. Result: There were 376 patients included in this study. The majority of patients were male (n=291,77.4%) with the median overall patient age of 58 years old. Most of MACE found in the patients were revascularization (n=113;30.1%). The prevalence of hypertension was 19.1%. There were significant differences in length of in hemoglobin (p=0.006), lymphocytes count (p=0.002), uric acid (p=0.032) and GFR (p=0.000) in the patients classified based on MACE. MACE was significantly associated with hypertension (PR=1.285;95%CI=1.102-1.498;p=0.006). Chi-square analysis showed that stroke (PR=2.386;95%CI=1.271-4.480;p=0.007), heart failure (PR=2.533;95%CI=1.574-4.078;p=0.000), and malignant arrhythmia (PR=1.820;95%CI=1.229-2.694;p=0.004) were significantly associated with hypertension. Association of hypertension and kidney disease were significantly associated with stroke (PR= 2.386;95%CI=1.271-4.480;p=0.007), malignant arrhythmia (PR=1.820;95%CI=1.229-2.694;p=0.004) and heart failure (PR=2.533;95%CI=1.574-4.078;p=0.000). Association of hypertension and COVID-19 were also significantly associated with malignant arrhythmia (PR= 2.253;95%CI=1.309-3.877;p=0.011). Conclusion: There were significant association between hypertension with MACE in the patients. Intervention on these factors can prevent further mortality.